MIMIX
LIVE

Serial Number

98873501

Owner

Revvity Health Sciences, Inc.

Attorney

Kevin Oliver

Filing Date

Nov 26, 2024

Add to watchlist:

No watchlists yet
View on USPTO

MIMIX Trademark

Serial Number: 98873501

MIMIX is a trademark filed by Revvity Health Sciences, Inc. on November 26, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). The application is currently pending registration.

Owner Contact Info

Revvity Health Sciences, Inc.

77 4th Avenue
Waltham, MA 02451

Entity Type: 03

Trademark Details

Filing Date

November 26, 2024

Registration Date

Not Registered

Published for Opposition

December 16, 2025

Goods & Services

Custom manufacture of cell line-delivered products in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, for medical and commercial applications; Custom manufacture of reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids

Biological preparations for laboratory, biopharmaceutical processing, and research purposes, for use as reference standards in science; Biological preparations for cancer research; Biological preparations for quality control of laboratory research; Cell line-derived nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, for use as reference standards for research purpose; Samples made of nucleic acids for use in biochemical or biological laboratory analysis for research purposes; Samples made of formalin and nucleic acids for use in a biochemical or biological laboratory analysis for research purposes; Samples made of formalin and cells for use in a biochemical or biological laboratory analysis for research purposes; Cell line-derived products in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, for scientific and research purposes, including for clinical investigations and for use in product testing; Reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for research purposes, namely, used for next generation sequencing, droplet-digital, Real-Time Polymerase Chain Reaction (PCR) or Sanger sequencing

cell line-derived reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used in clinical medical samples; Reference standard substances in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for clinical tests for medical purposes; medical reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for next generation sequencing, droplet-digital, Real-Time Polymerase Chain Reaction (PCR) or Sanger sequencing; medical reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for detecting chromosomal abnormalities; medical reference standards in the nature of nucleic acids, formalin-fixed paraffin-embedded (FFPE) cells, formalin-fixed paraffin-embedded (FFPE) nucleic acids, and formalin-compromised nucleic acids, used for analysing biological samples

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 10, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 16, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 16, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 10, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 18, 2025 CNSA
ASSIGNED TO EXAMINER
Nov 7, 2025 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 26, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 26, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 26, 2025 TROA
ASSIGNED TO LIE
Jun 11, 2025 ALIE
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 27, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 27, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 27, 2025 CNRT
ASSIGNED TO EXAMINER
May 19, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 26, 2025 NWOS
NEW APPLICATION ENTERED
Nov 26, 2024 NWAP